zika

Congress Passes Zika Funding Bill

Congress passed and President Obama signed a 10-week continuing resolution, which includes $1.1 billion for Zika virus research.
Read

Zika in ASM Journals

Read a collection of open-access artiles from ASM's journals.
Read

Zika In The Lab

Follow Dr. Vincent Racaniello’s lab adventures with the Zika Virus in his blog, Zika Diaries.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

Antimicrobial Chemotherapy
Division A is concerned with the discovery, mode of action, development and use of antimicrobial agents, and the mechanisms by which infective agents develop resistance to these compounds.

2013 Officers - all terms run from July 1, 2012 to June 30, 2013

Chair
Hanna M. Wexler
UCLA School of Medicine
Los Angeles, CA
hwexler@ucla.edu
310-268-3404

Chair-Elect
Jeffrey D. Alder
Bayer Healthcare Pharmaceuticals Inc.
Montville, NJ
jeff-lisa-alder@hotmail.com

Councilor
Linda A. Miller
GLAXOSMITHKLINE
Collegeville, PA
linda.a.miller@gsk.com
610-917-6280

Division A is part of Divisional Group II - Pathogenesis and Host Response Mechanisms

Divisional Group Representative
Victor DiRita
University of Michigan
Ann Arbor, MI
vdirita@umich.edu


Join DivANet

Website

 

TPL_asm2013_SEARCH

91500